Castle Biosciences Says New Data Supporting The Utility Of Its DecisionDx-SCC Test In Patients With High-risk Cutaneous Squamous Cell Carcinoma Tumors Located On The Head And Neck (H&N) Will Be Shared At 56Th American College Of MOHS Surgery Meeting
Castle Biosciences Says New Data Supporting The Utility Of Its DecisionDx-SCC Test In Patients With High-risk Cutaneous Squamous Cell Carcinoma Tumors Located On The Head And Neck (H&N) Will Be Shared At 56Th American College Of MOHS Surgery Meeting
Castle Biosciences表示，支持其DecisionDX-SCC测试在头颈部（H＆N）高风险皮肤鳞状细胞癌患者中的实用性的新数据将在第56届美国卫生部外科学会会议上分享
Castle Biosciences Says New Data Supporting The Utility Of Its DecisionDx-SCC Test In Patients With High-risk Cutaneous Squamous Cell Carcinoma Tumors Located On The Head And Neck (H&N) Will Be Shared At 56Th American College Of MOHS Surgery Meeting
Castle Biosciences表示，支持其DecisionDX-SCC测试在头颈部（H＆N）高风险皮肤鳞状细胞癌患者中的实用性的新数据将在第56届美国卫生部外科学会会议上分享
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。